Qelbree is a prescription medication that has been approved by the FDA for the treatment of attention-deficit/hyperactivity disorder (ADHD) in pediatric patients aged 6 to 17 years old. It is a non-stimulant medication that works by targeting the norepinephrine transporter, which helps regulate the levels of norepinephrine in the brain.

One of the key benefits of Qelbree is that it does not have the potential for abuse or dependence like some other ADHD medications, making it a safer option for patients who may be at risk for substance abuse. Additionally, Qelbree has been shown to improve symptoms of ADHD, such as inattention, hyperactivity, and impulsivity, in clinical trials.

As with any medication, there are potential side effects to be aware of when taking Qelbree. Some common side effects may include drowsiness, fatigue, irritability, and decreased appetite. It is important to discuss any concerns or side effects with your healthcare provider to determine the best course of action.

It is important to follow your healthcare provider’s instructions when taking Qelbree and to not adjust your dosage without consulting them first. It is also important to monitor for any changes in mood or behavior while taking this medication, as it may affect certain individuals differently.

Overall, Qelbree is a promising option for the treatment of ADHD in pediatric patients and may offer a safe and effective alternative to stimulant medications. If you have any questions or concerns about Qelbree, be sure to speak with your healthcare provider for more information.